IL10 and bronchopulmonary dysplasia: Further studies may find that enhancement of endogenous IL-10 release or use of exogenous IL-10 could have therapeutic potential for serious inflammatory disorders [30] in the perinatal period such as preterm labor [31], or white matter injury and BPD in the newborn.